CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to MIRM

Brelovitug 300 mg

Phase 3
Mirum Pharmaceuticals, Inc. (MIRM)

Phase 3

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Aug '26
MIRMPhase 3

Brelovitug 300 mg Phase 3 Est. Readout

Brelovitug 300 mg
Aug 2026~STALE
CT.gov
00%
Competitive Landscape

0 competitors in Chronic Hepatitis D Infection

View Full Landscape
Drug Information

Target Indication

Chronic Hepatitis D Infection

Clinical Trial

NCT07298330

Last updated: 6/26/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.